Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication.

Literature DB >> 20213393

Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication.

Norman Jaffe¹.

Abstract

Entities: Disease

Mesh：

Year: 2009 PMID： 20213393 DOI： 10.1007/978-1-4419-0284-9_11

Source DB: PubMed Journal: Cancer Treat Res ISSN： 0927-3042

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.

Authors: Zhehai Li; Qiande Liao; Yuchi Wu; Mingmei Liao; Yuqin Hao; Shengbin Zhang; Shipeng Song; Bing Li; Yang-de Zhang
Journal: Pathol Oncol Res Date: 2012-01-05 Impact factor: 3.201

2. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.

Authors: H Zhu; H Cai; M Tang; J Tang
Journal: Clin Transl Oncol Date: 2013-12-12 Impact factor: 3.405

3. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.

Authors: Huanli Zhao; Yuhui Wu; Yang Chen; Hongmei Liu
Journal: Int J Clin Oncol Date: 2015-06-16 Impact factor: 3.402

4. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors: Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal: Med Oncol Date: 2012-07-31 Impact factor: 3.064

5. The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.

Authors: Jun Chen; Yang Song; Jing Yang; Li Gong; Peng Zhao; Yong Zhang; Haichuan Su
Journal: Mol Cell Biochem Date: 2013-09-14 Impact factor: 3.396

Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication.

1. Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.

2. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.

3. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.

4. Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

5. The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.

6. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.

7. Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma.

8. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.

9. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.

10. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.